Qingshuang Liang

Qingshuang Liang

Auto-generated profile, based on publicly available information

Qingshuang Liang

Fujian Normal University

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

24 February 2020 in European Journal of Inorganic Chemistry
Verified
Journal Article
Closed access
PDF file
SZShuting Zhu
Shuting Zhu
QLQingshuang Liang
Qingshuang Liang
YXYating Xu
Yating Xu
HFHanping Fu
Hanping Fu
XXXiufeng Xiao
Xiufeng Xiao

9 January 2021 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
YXYating Xu
Yating Xu
HFHanping Fu
Hanping Fu
LZLing Zhao
Ling Zhao
LJLishan Jian
Lishan Jian
QLQingshuang Liang
Qingshuang Liang
XXXiufeng Xiao
Xiufeng Xiao
The generation of H 2 O 2 on BiOCl(001) originates from O 2 reduction, while there are two pathways on BiOCl(010).

23 January 2025 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
SRShufen Ren
Shufen Ren
QZQing Zhang
Qing Zhang
HFHanping Fu
Hanping Fu
JCJiayun Cheng
Jiayun Cheng
YXYan Xie
Yan Xie
XXXiufeng Xiao
Xiufeng Xiao
Insufficient reactive oxygen species (ROS) generation and radioresistance resulting from the intrinsic features of tumors consistently give rise to unsatisfactory therapeutic outcomes of radiotherapy (RT). Developing a multifunctional radiosensitizer capable of activating ROS-induced apoptosis and achieving multimodal therapy is highly imperative yet remains a challenge so far. Herein, a multifunctional therapeutic nanoplatform based on Bi2WO6–BP heterojunctions for multimodal synergistic tumor treatment with glutathione depletion and amplifying ROS generation is rationally designed. Rich in high-Z elements, Bi2WO6–BP heterojunctions are able to deposit higher radiation doses into cancer cells, enhancing the radiotherapy effect. The Z-scheme heterojunction structure facilitates the X-ray-triggered catalytic process that catalyzes intracellular overproduced H2O2 into highly toxic ˙OH, which thus enhances ROS generation in a hypoxic environment. The unique sub-band structures of BP NSs and the synergistic effect between Bi2WO6 and BP significantly boosted 1O2 generation. Meanwhile, the acidic TME can trigger the cycle conversion of W from W5+ to W6+, and the redox reaction between W6+ and GSH consumes the high level of GSH in tumor cells and increases the production of ROS. The mild photothermal effect produced by the Bi2WO6–BP heterojunction could further enhance the ROS generation. Both in vitro and in vivo experiments showed that the as-prepared Bi2WO6–BP heterojunction possesses high synergistic therapeutic efficacy. This work offers a viable approach to build a multifunctional radiosensitizer with TME-triggered multiple synergistic therapies for deep tumors.

31 October 2022 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
LLLiran Liu
Liran Liu
HFHanping Fu
Hanping Fu
YZYating Zeng
Yating Zeng
LFLi Feng
Li Feng
TZTianxiang Zhang
Tianxiang Zhang
XXXiufeng Xiao
Xiufeng Xiao
Efficient production of H 2 O 2 via metal Bi and defect co-modified BiOCl.